Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses
- 10 November 2017
- journal article
- letter
- Published by Springer Nature in Science China Life Sciences
- Vol. 60 (12) , 1399-1402
- https://doi.org/10.1007/s11427-017-9189-3
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Bat Severe Acute Respiratory Syndrome-Like Coronavirus WIV1 Encodes an Extra Accessory Protein, ORFX, Involved in Modulation of the Host Immune ResponseJournal of Virology, 2016
- Bat origin of human coronavirusesVirology Journal, 2015
- Identification of immunogenic determinants of the spike protein of SARS-like coronavirusVirologica Sinica, 2013
- Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodiesProceedings of the National Academy of Sciences, 2007
- SARS Vaccine DevelopmentEmerging Infectious Diseases, 2005
- Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains Multiple Conformation-Dependent Epitopes that Induce Highly Potent Neutralizing AntibodiesThe Journal of Immunology, 2005
- A 193-Amino Acid Fragment of the SARS Coronavirus S Protein Efficiently Binds Angiotensin-converting Enzyme 2Journal of Biological Chemistry, 2004
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003